Longeveron Reveals Public Offering of Up to $17.5 Million
Longeveron Inc. Announces Upcoming Offering Potential revenue from a recent offering could reach $12.5 million, with initial amounts estimated around $500,000 before fees are deducted. On August 8, 2025, Miami-based Longeveron Inc. (NASDAQ: LGVN) revealed it is working on cellular therapies aimed at treating rare pediatric conditions. The company has also introduced short-term warrants that […]